Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

08 May 2018 : Clinical Research  

Effect of Thunder-Fire Moxibustion on Pain, Quality of Life, and Tension of Multifidus in Patients with Primary Osteoporosis: A Randomized Controlled Trial

Dao-Ming XuABCDEF, Huaning XuBDF, Jing LiuBEF, Tong WangACG, Wenzhong WuAG, Lanying LiuAB, Qianmo TianBEF, Hanjun LiDF, Lili ZhangCD, Yana CaoBEF

DOI: 10.12659/MSM.909725

Med Sci Monit 2018; 24: CLR2937-2945

Abstract

BACKGROUND: Primary osteoporosis is a common disease among postmenopausal women and the elderly; low back pain is the most typical clinical manifestation an is the primary reason for a clinic visit, and directly affects patients’ quality of life. Anti-osteoporosis medications have undesirable side effects, and many kinds of special traditional Chinese moxibustion methods have been widely used in the clinical treatment of osteoporosis low back pain. The purpose of this study was to observe whether thunder-fire moxibustion therapy, compared to calcium supplements alone, can ease osteoporosis low back pain, improve quality of life, and reduce tension of the multifidus.

MATERIAL AND METHODS: Sixty-three eligible patients were enrolled in the study (7 of these patients did not finish the study and are not included in analysis). Participants were randomly divided into 2 groups: a moxibustion group that received calcium carbonate D3 and thunder-fire moxibustion therapy, and a control group that received calcium carbonate D3 only. Level of pain experienced, assessed using the visual analogue scale (VAS), and quality of life (SF-36) were measured pre-treatment, at the end of 4 weeks of treatment, and at a 1-month post-treatment evaluation. Changes in values of Young’s modulus of the multifidus were also collected before and after treatment.

RESULTS: After 4 weeks of treatment and at 1 month after treatment had ended, low back pain in both groups was reduced relative to pre-treatment levels. The moxibustion group was significantly improved at BP, GH, SF, and MH dimensions compared to pre-treatment levels. The control group improved in BP dimensions, but not to the same extent as the moxibustion group. Similarly, after treatment for 4 weeks with moxibustion, multifidus tension was significantly reduced.

CONCLUSIONS: Thunder-fire moxibustion is an effective method for treating low back pain due to primary osteoporosis.

Keywords: Low Back Pain, Osteoporosis, SF-36, Thunder-Fire Moxibustion, VAS, Yang’s Modulus

Add Comment 0 Comments

Editorial

01 July 2025 : Editorial  

Editorial: The 2025 World Health Assembly Pandemic Agreement and the 2024 Amendments to the International Health Regulations Combine for Pandemic Preparedness and Response

Dinah V. Parums

DOI: 10.12659/MSM.950411

Med Sci Monit 2025; 31:e950411

0:00

In Press

Clinical Research  

Audiological and Middle Ear Outcomes in Ukrainian Soldiers with Traumatic Tympanic Membrane Perforation

Med Sci Monit In Press; DOI: 10.12659/MSM.948326  

Clinical Research  

Association Between Central Obesity and Membranous Nephropathy

Med Sci Monit In Press; DOI: 10.12659/MSM.947570  

Clinical Research  

Development and Validation of a Predictive Nomogram for Early Postoperative Recurrence in Non-Small Cell Lu...

Med Sci Monit In Press; DOI: 10.12659/MSM.948441  

Clinical Research  

Effects of Heated Tobacco Use on Blood Parameters and Cardiovascular Risk in Healthy Men

Med Sci Monit In Press; DOI: 10.12659/MSM.948556  

Most Viewed Current Articles

17 Jan 2024 : Review article   10,151,529

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research   704,406

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Mar 2024 : Editorial   33,581

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...

DOI :10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

28 Jan 2024 : Review article   27,952

A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future

DOI :10.12659/MSM.943912

Med Sci Monit 2024; 30:e943912

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750